Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Manage alerts
Active alerts for Mafatlal Industries
Add new alert
MAFATIND •
NSE
Mafatlal Industries
₹140.91
1.28 (0.92%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
ScoutQuest •
11 hours ago
Mafatlal Industries posts record annual revenue of INR 3870.4 Cr, up 38% YoY. Q4FY26 revenue rose 96% YoY to INR 883.2 Cr; orderbook at INR 775 Cr.
News18 •
11 hours ago
Mafatlal Industries appoints Priyavrata Mafatlal as CEO & MD from June 2026. Leadership consolidation aims to boost growth, global market presence, and decision-making.
BSE •
13 hours ago
Mafatlal Industries' board approved FY26 financial results and a final dividend of Rs. 1.25/share, subject to AGM approval. CEO M.B. Raghunath to retire on May 31, 2026; Priyavrata Mafatlal appointed as CEO and MD from June 1, 2026.
BSE •
3 weeks ago
Mafatlal Industries schedules board meeting on May 5, 2026, to approve audited financial results and consider dividend recommendation for FY26. Trading window remains closed until 48 hours post-results; shareholders advised to update details and claim unclaimed dividends by Feb 4, 2027.
Livesquawk •
2 months ago
Mafatlal Industries secures a significant 1.14B rupee order. This development enhances Mafatlal Industries' market position.
ScoutQuest •
2 months ago
Mafatlal Industries Ltd secures OCAC order for 500 robotic labs in Odisha. Project spans 16 districts under School and Mass Education, over 5 years.
The Hindu BusinessLine •
3 months ago
Mafatlal Industries launches D2C platform 'Mafatlal MedFits' for medical apparel. The platform offers scrubs, lab coats, caps, and allied products for healthcare professionals.
Marketsmojo •
3 months ago
Mafatlal Industries Ltd reports sharp decline in Dec 2025 quarter, moving to a negative financial trend. Revenue and profitability dropped significantly, leading to a downgrade to 'Sell' on 5 Jan 2026.
ScoutQuest •
3 months ago
Mafatlal Industries' Q3 revenue fell 21.2% YoY to ₹717.4 Cr due to order deferment. 9MFY26 revenue rose 26.7% YoY to ₹2,987.2 Cr; PBT down 40% in Q3 but up 30.2% in 9M.
BSE •
3 months ago
Mafatlal Industries' Board approved unaudited financial results for Q3 and nine months ended Dec 31, 2025. Price Waterhouse reviewed and gave moderate assurance on both standalone and consolidated results, finding no material misstatements.